Olanzapine induced neuroleptic malignant syndrome, treated with electroconvulsive therapy (ECT)-A case report.

Authors:
Mustafa Ali
Mustafa Ali
El-Khomes University
Soumitra Das
Soumitra Das
Government T. D. Medical College
Vandanam | India
Jagadisha Thirthalli
Jagadisha Thirthalli
National Institute of Mental Health and Neurosciences
India

Asian J Psychiatr 2017 Dec 14;30:230-231. Epub 2017 Jul 14.

NIMHANS, Bengaluru, India; Professor of Psychiatry and I/C Head of Psychiatric Rehabilitation Services, National Institute of Mental Health & Neurosciences (NIMHANS), Bengaluru 560029, India; NIMHANS, Bengaluru, India. Electronic address:

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ajp.2017.07.020DOI Listing
December 2017
13 Reads

Publication Analysis

Top Keywords

electroconvulsive therapy
4
treated electroconvulsive
4
therapy ect-a
4
ect-a case
4
case report
4
malignant syndrome
4
syndrome treated
4
induced neuroleptic
4
olanzapine induced
4
neuroleptic malignant
4
case
1
neuroleptic
1
report
1
ect-a
1
malignant
1
treated
1
olanzapine
1
electroconvulsive
1
therapy
1
syndrome
1

Similar Publications

Electroconvulsive treatment of neuroleptic malignant syndrome: a review and report of cases.

Aust N Z J Psychiatry 1999 Oct;33(5):650-9

Neuropsychiatric Institute, The Prince of Wales Hospital, Randwick, New South Wales, Australia.

Objective: Neuroleptic malignant syndrome (NMS) is a potentially lethal adverse effect of neuroleptic medication, with no satisfactory treatment currently available. Electroconvulsive therapy (ECT) has been anecdotally reported to be effective in its treatment. We review 45 published case reports of ECT for NMS and describe nine new cases, to examine its effectiveness, the likelihood of adverse reactions, and the theoretical implications of such treatment. Read More

View Article
October 1999

Neuroleptic Malignant Syndrome: Neuroleptic Rechallenge After Electroconvulsive Therapy.

Convuls Ther 1993 ;9(3):198-204

Eitanim Psychiatric Hospital and Hebrew University Hadassah Medical School, Jerusalem, Israel.

The necessity of neuroleptic rechallenge in patients who have experienced neuroleptic malignant syndrome (NMS) has been discussed in recent articles. Electroconvulsive therapy (ECT) has been proposed as an alternative treatment to neuroleptics. In cases where ECT fails, neuroleptic rechallenge remains the only alternative. Read More

View Article
January 1993

Successful treatment of hydroxyzine and dexclorfeniramine maleate in combination with electroconvulsive therapy in a neuroleptic malignant catatonia: a case report.

Int Clin Psychopharmacol 2015 Mar;30(2):115-7

aHospital Benito Menni CASM, Dr Antoni Pujadas bFIDMAG Germanes Hospitalàries Research Foundation, CIBERSAM, Barcelona, Spain.

Malign neuroleptic syndrome is a potentially life-threatening condition that is normally treated with electroconvulsive therapy (ECT). In this case report, we discuss a severely agitated and catatonic bipolar I patient who developed a neuroleptic malignant syndrome and did not improve with benzodiazepines and ECT. On the basis of anecdotal reports of the positive effects of antihistamines in psychosis and ECT, we treated our case with a combination of two antihistamines, hydroxyzine and dexclorfeniramine maleate, and ECT, which improved the clinical picture to the point of clinical remission. Read More

View Article
March 2015

ECT during and after the neuroleptic malignant syndrome: case report.

Authors:
J R Hughes

J Clin Psychiatry 1986 Jan;47(1):42-3

A patient with the neuroleptic malignant syndrome had a cardiac arrest after the administration of modified ECT. After the syndrome resolved, ECT was given without problems. These results suggest ECT is risky during but not after the neuroleptic malignant syndrome. Read More

View Article
January 1986